Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 293,477 | 394,553 | 485,680 | 435,321 | 507,144 |
| Marketable Securities | 571,930 | 644,622 | 823,251 | 977,827 | 962,553 |
| Receivables | N/A | N/A | 15,218 | N/A | N/A |
| Other current assets | 1,226 | 1,194 | 1,567 | 2,511 | 5,674 |
| TOTAL | $897,234 | $1,055,509 | $1,341,745 | $1,431,622 | $1,495,655 |
| Non-Current Assets | |||||
| PPE Net | 38,865 | 40,012 | 40,350 | 41,376 | 40,846 |
| Investments And Advances | 425,449 | 319,472 | 92,522 | 38,885 | 32,699 |
| Other Non-Current Assets | 42,614 | 34,973 | 35,198 | 35,975 | 35,080 |
| TOTAL | $506,928 | $394,457 | $168,070 | $116,236 | $108,625 |
| Total Assets | $1,404,162 | $1,449,966 | $1,509,815 | $1,547,858 | $1,604,280 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,779 | 4,817 | 4,235 | 1,626 | 1,071 |
| Accrued Expenses | 53,165 | 28,886 | 26,634 | 26,690 | 47,145 |
| Other current liabilities | 320,301 | 15,296 | 15,488 | 21,418 | 23,483 |
| TOTAL | $378,245 | $54,251 | $51,412 | $54,610 | $71,699 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 63,626 | 383,438 | 385,698 | 387,895 | 382,050 |
| TOTAL | $63,626 | $383,438 | $385,698 | $387,895 | $382,050 |
| Total Liabilities | $441,871 | $437,689 | $437,110 | $442,505 | $453,749 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 122,833 | 122,126 | 121,640 | 121,192 | 120,984 |
| Common Shares | 1,548 | 1,545 | 1,541 | 1,537 | 1,531 |
| Retained earnings | -644,996 | -569,735 | -485,147 | -424,456 | -354,415 |
| Other shareholders' equity | -2,499 | -521 | -368 | -232 | -245 |
| TOTAL | $962,291 | $1,012,277 | $1,072,705 | $1,105,353 | $1,150,531 |
| Total Liabilities And Equity | $1,404,162 | $1,449,966 | $1,509,815 | $1,547,858 | $1,604,280 |